Carlsmed, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Carlsmed, Inc. (CARL) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 34.65 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-05
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 34.65K shares.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 42.32K shares.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 918.76K shares.
- Carlsmed, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.84M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 34.65K shares 10-Q · filed 2026-08-05 | 76.96K shares derived: sum of 3 quarters · filed 2026-08-05 | 995.72K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 34.65K shares 10-Q · filed 2026-05-05 | 76.96K shares derived: sum of 2 quarters · filed 2026-05-05 | 995.72K shares derived: sum of 3 quarters · filed 2026-05-05 | |
| 2025-12-31 | 42.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 961.08K shares derived: sum of 2 quarters · filed 2026-02-25 | 1.84M shares 10-K · filed 2026-02-25 | |
| 2025-09-30 | 918.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.80M shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 879.27K shares 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |